Abstract
Extramedullary disease (EMD) occurs as a secondary event in 5–10% of patients with relapsed/refractory multiple myeloma (RRMM) and prognosis is unfavorable [1]. EMD affecting the central nervous sy...
Funding Information
  • Medical Faculty of Ludwig-Maximilians-University in Munich (FöFoLe, Reg.-Nr. 1089)

This publication has 19 references indexed in Scilit: